1995 Saab 9-3 Convertible on 2040-cars

Auto blog

First test drive shows promise of Saab 9-3 EV

We can't read Swedish, so when it comes to a first-drive review of a Saab 9-3 electric-vehicle prototype, we'll trust Inside EVs' translation of a write-up from Swedish automotive publication Elbilen i Sverige. And it's a decent one. The write-up, that is. The translation, too, we hope. Taken to the test track, the Saab was found to be quieter than a Tesla Model S and had the stability commensurate for a car that tipped the scales at about 4,000 pounds. The sedan accelerated from 0 to 62 miles per hour in 10 seconds, though the goal is to bring that time down to 8.5 seconds. The prototype also uses a 37-kWh prototype battery made by China-based Kai Johan Jiang Annual National Modern Energy Holdings that should be good for over 180 miles (and there's room for a bigger pack in the car, apparently). The 9-3's electric motor will be able to deliver 200 horsepower but, for testing purposes, it was limited to about 140 horsepower. The overall impression was that the car is not yet ready for prime time, but has a lot of promise. When prototype becomes production is the real question, given the financial condition of Saab parent National Electric Vehicle Sweden (NEVS). The company acquired the brand in 2012 and started making cars at Saab's Trollhattan plant in Sweden last year, but production stopped in May because of cash-flow issues. Late last month, Swedish courts denied NEVS protection from its creditors, so the company is now looking to restructure.

Junkyard Gem: 2004 Saab 9-5 Arc Wagon

As I work on my project of documenting automotive history via the machinery I find in car graveyards around the country, blank spots in the junkyard record keep showing themselves. I've remedied the lack of discarded BMW 3- and 5-Series cars in recent months, through the E46 and E39 respectively, and now I'm trying to move past the 900 in the Saab timeline. We've got the 9000 covered, and now it's the turn of the 9-3 and 9-5. Here's an '04 9-5 Arc Wagon, found in a Denver yard recently (I shot a 9-3 on the same trip and you'll see it in the near future). General Motors took over Saab in 2000, after more than a decade of 50% ownership, and so the 9-5 (or 95 if you prefer) had plenty of Opel/Holden/Vauxhall DNA in its cells. Its closest American-market relative (other than the 9-3) was the Saturn L-Series. However, you couldn't get a Saturn with a proper Saab engine under the hood, and by "proper" we mean one descended from the original Triumph Slant-4. This 2.3T turbocharged version sent 220 horsepower to the front wheels, making this a nicely quick wagon. It appears that this car endured some lean times as it approached the end of its road, with the kind of leaky-side-glass repair you do only when you know you're a car's final owner. You could get the 9-5 Wagon as the Linear, Arc, or Aero models in 2004. The Aero was the factory-hot-rod version, while the Arc was more about luxury. The leather seats in this Arc still look pretty good. Even though this car's ancestry is more German than Swedish, it has the traditional Saab console-mounted ignition switch. When it came time for The General to sell Subaru Imprezas with Saab badging, however, the ignition switches stayed in the non-Saab locations. At least the Saab-badged Chevy Trailblazer had the switch in the Trollhatten-approved location. It doesn't look as quirky as the early Saabs, which were born from Flying Barrels, but it stood up well against the competing cars offered to America's ever-shrinking pool of station wagon shoppers. Built in Sweden by Swedes! Would this have happened with an Audi wagon?   Featured Gallery Junked 2004 Saab 9-5 Arc Wagon View 26 Photos Auto News Saab Automotive History Wagon Junkyard Gems

NEVS, the company that took over Saab, gets new majority owner

Chinese real estate conglomerate Evergrande Group, a key investor behind troubled electric vehicle startup Faraday Future, has acquired a 51 percent stake in NEVS. That's the Chinese-backed Swedish electric vehicle company that purchased the assets of Saab out of bankruptcy in 2012. The investment by subsidiary Evergrande Health Industry Group was valued at the equivalent of $930 million and is expected to help NEVS develop new EVs. Evergrande said it paid the first installment of $430 million on Jan. 15, with the remainder due by the end of the month. The remaining 49 percent stake is controlled by a holding company controlled by NEVS founder Kai Johan Jiang. "It means that NEVS will get a financial (sic) strong main owner who is very interested in developing our vision about green mobility transport solutions for the future," NEVS CEO Stefan Tilk said in a statement. NEVS, short for National Electric Vehicle Sweden, owns production facilities in Trollhattan, Sweden, and Tianjin, China, with another under construction in Shanghai. In late 2017 the company launched what apparently was limited production of the 9-3 EV, an electric vehicle based — you guessed it — on the old Saab 9-3 platform. The company now says it will be built in Tianjin starting later this year, with components coming from Trollhattan. It boasts a 186-mile range, in-car WiFi and a cabin air filter for the notoriously smoggy Chinese air. It also showed a battery-electric 9-3X concept at CES Asia in 2017, which is likely to be its next model pegged for production. The South China Morning Post, citing local media reports, says two of NEVS' models meet the standards for mass production in China. This content is hosted by a third party. To view it, please update your privacy preferences. Manage Settings. Definitely the best promotional video we've ever seen. Evergrande Health first came to Faraday Future's rescue back in 2017 with a promised $2 billion investment, but the two sides later went into arbitration in Hong Kong over a dispute about money following the first infusion of $800 million, leading the automaker to cut staff and wages last year, casting the future of FF into doubt. At the end of 2018, Faraday announced it had entered into a new restructuring agreement with an Evergrande Health subsidiary that sees them end litigation and jettison the previous investment agreement, taking Evergrande's investment in the company to 32 percent.